The CXCL12-CXCR4 pathway is another potential target to decrease TAM recruitment, the blockade of which mobilized CD8+ T cells to the tumor and reduced TAM accumulation in multiple cancers 171-173. The gene discussed is CD8A; the disease is neoplasm.